Non-insulin-dependent Diabetes Mellitus and Insulin Resistance in Chronic Hepatitis C Patients Treated With Combination Therapy With Pegylated Interferon and Ribavirin in Taiwan.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Peginterferon alfa; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Aug 2009 Actual number of patients (400) added as reported by ClinicalTrials.gov.
- 07 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Aug 2009 Biomarkers information updated